Financial Architects (New Jersey)’s Catalyst Pharmaceutical CPRX Stock Holding History

Financial Architects (New Jersey)’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-30,000	Closed	-$90K	–	218
2015 Q3	$90K	Hold	30,000	–	–	0.04%	200
2015 Q2	$124K	Hold	30,000	–	–	0.04%	265
2015 Q1	$130K	Hold	30,000	–	–	0.05%	249
2014 Q4	$89K	Hold	30,000	–	–	0.04%	269
2014 Q3	$100K	Hold	30,000	–	–	0.05%	220
2014 Q2	$76K	Hold	30,000	–	–	0.04%	267
2014 Q1	$68K	Hold	30,000	–	–	0.04%	148
2013 Q4	$59K	Buy	+30,000	New	+$60.6K	0.03%	151

Other funds holding CPRX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Financial Architects (New Jersey)'s CPRX Position: Q4 2015 in Review

Financial Architects (New Jersey) sold out of Catalyst Pharmaceutical (CPRX) in Q4 2015, closing a stake of 30,000 shares — an estimated $90K sold.

Financial Architects (New Jersey) first reported a position in CPRX in Q4 2013 and held it in 8 quarters. The position peaked at $130K in Q1 2015. 85 funds tracked by Wall St. Rank hold CPRX as of Q4 2015.

Financial Architects (New Jersey) reported no remaining Catalyst Pharmaceutical position as of Q4 2015 after selling out during the quarter.
Financial Architects (New Jersey) sold 30,000 Catalyst Pharmaceutical shares in Q4 2015, an estimated $90K.
Financial Architects (New Jersey) first reported a position in Catalyst Pharmaceutical in Q4 2013 and held it in 8 quarters.
Financial Architects (New Jersey)'s Catalyst Pharmaceutical position peaked at $130K in Q1 2015.
85 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2015.

Based on Financial Architects (New Jersey)'s 13F filing for Q4 2015, filed 16 Feb 2016.